Mirum Pharmaceuticals (MIRM) Work In Process (2021 - 2026)

Mirum Pharmaceuticals' Work In Process history runs 6 years deep, the most recent figure standing at $19.5 million for Q1 2026.

• On a quarterly basis, Work In Process rose 23.21% year-over-year to $19.5 million in Q1 2026; TTM through Mar 2026 was $19.5 million, a 23.21% increase from a year earlier, with the FY2025 full-year figure at $18.5 million, up 14.82% from the prior year.
• Work In Process improved to $19.5 million in Q1 2026 per MIRM's latest filing, from $18.5 million in the prior quarter.
• Across five years, Work In Process topped out at $19.5 million in Q1 2026 and bottomed at $553000.0 in Q1 2022.
• The 5-year median for Work In Process is $10.8 million (2024), against an average of $11.3 million.
• Across the five-year window, Work In Process soared 1072.51% in 2023 and increased 14.82% in 2025, its largest moves.
• Year by year, Work In Process stood at $5.4 million in 2022, then jumped by 84.51% to $9.9 million in 2023, then jumped by 62.96% to $16.1 million in 2024, then climbed by 14.82% to $18.5 million in 2025, then grew by 5.49% to $19.5 million in 2026.
• Per Business Quant, the three latest MIRM Work In Process figures stand at $19.5 million (Q1 2026), $18.5 million (Q4 2025), and $18.3 million (Q3 2025).